Elimination of HIV-1-infected cells by broadly neutralizing antibodies

被引:0
|
作者
Timothée Bruel
Florence Guivel-Benhassine
Sonia Amraoui
Marine Malbec
Léa Richard
Katia Bourdic
Daniel Aaron Donahue
Valérie Lorin
Nicoletta Casartelli
Nicolas Noël
Olivier Lambotte
Hugo Mouquet
Olivier Schwartz
机构
[1] Virus and Immunity Unit,Department of Virology
[2] Institut Pasteur,Department of Immunology
[3] CNRS-URA 3015,Division of Immuno
[4] Laboratory of Humoral Response to Pathogens,Virology
[5] Institut Pasteur,undefined
[6] CNRS-URA 1961,undefined
[7] Université Paris Sud,undefined
[8] UMR-1184,undefined
[9] CEA,undefined
[10] DSV/iMETI,undefined
[11] IDMIT,undefined
[12] Inserm,undefined
[13] U1184,undefined
[14] Center for Immunology of Viral Infections and Autoimmune Diseases,undefined
[15] APHP,undefined
[16] Service de Médecine Interne–Immunologie Clinique,undefined
[17] Hôpitaux Universitaires Paris Sud,undefined
[18] Vaccine Research Institute,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Fc region of HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) is required for suppressing viraemia, through mechanisms which remain poorly understood. Here, we identify bNAbs that exert antibody-dependent cellular cytotoxicity (ADCC) in cell culture and kill HIV-1-infected lymphocytes through natural killer (NK) engagement. These antibodies target the CD4-binding site, the glycans/V3 and V1/V2 loops on gp120, or the gp41 moiety. The landscape of Env epitope exposure at the surface and the sensitivity of infected cells to ADCC vary considerably between viral strains. Efficient ADCC requires sustained cell surface binding of bNAbs to Env, and combining bNAbs allows a potent killing activity. Furthermore, reactivated infected cells from HIV-positive individuals expose heterogeneous Env epitope patterns, with levels that are often but not always sufficient to trigger killing by bNAbs. Our study delineates the parameters controlling ADCC activity of bNAbs, and supports the use of the most potent antibodies to clear the viral reservoir.
引用
收藏
相关论文
共 50 条
  • [1] Elimination of HIV-1-infected cells by broadly neutralizing antibodies
    Bruel, Timothee
    Guivel-Benhassine, Florence
    Amraoui, Sonia
    Malbec, Marine
    Richard, Lea
    Bourdic, Katia
    Donahue, Daniel Aaron
    Lorin, Valerie
    Casartelli, Nicoletta
    Noel, Nicolas
    Lambotte, Olivier
    Mouquet, Hugo
    Schwartz, Olivier
    NATURE COMMUNICATIONS, 2016, 7
  • [2] Early development of broadly neutralizing antibodies in HIV-1-infected infants
    Goo, Leslie
    Chohan, Vrasha
    Nduati, Ruth
    Overbaugh, Julie
    NATURE MEDICINE, 2014, 20 (06) : 655 - 658
  • [3] Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
    Lu, Ching-Lan
    Murakowski, Dariusz K.
    Bournazos, Stylianos
    Schoofs, Till
    Sarkar, Debolina
    Halper-Stromberg, Ariel
    Horwitz, Joshua A.
    Nogueira, Lilian
    Golijanin, Jovana
    Gazumyan, Anna
    Ravetch, Jeffrey V.
    Caskey, Marina
    Chakraborty, Arup K.
    Nussenzweig, Michel C.
    SCIENCE, 2016, 352 (6288) : 1001 - 1004
  • [4] Killing of HIV-1-infected cells by neutralizing antibodies
    Bruel, T.
    Benhassine, F. Guivel
    Lorin, V.
    Baleux, F.
    Jacob, H. Lortat
    Bourdic, K.
    Noel, N.
    Lambotte, O.
    Mouquet, H.
    Schwartz, O.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 5 - 5
  • [5] Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
    Boutin, Marianne
    Vezina, Dani
    Ding, Shilei
    Prevost, Jeremie
    Laumaea, Annemarie
    Marchitto, Lorie
    Anand, Sai Priya
    Medjahed, Halima
    Gendron-Lepage, Gabrielle
    Bourassa, Catherine
    Goyette, Guillaume
    Clark, Andrew
    Richard, Jonathan
    Finzi, Andres
    MBIO, 2022, 13 (03):
  • [6] Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies
    Moody, M. Anthony
    Pedroza-Pacheco, Isabela
    Vandergrift, Nathan A.
    Chui, Cecilia
    Lloyd, Krissey E.
    Parks, Robert
    Soderberg, Kelly A.
    Ogbe, Ane T.
    Cohen, Myron S.
    Liao, Hua-Xin
    Gao, Feng
    McMichael, Andrew J.
    Montefiori, David C.
    Verkoczy, Laurent
    Kelsoe, Garnett
    Huang, Jinghe
    Shea, Patrick R.
    Connors, Mark
    Borrow, Persephone
    Haynes, Barton F.
    SCIENCE IMMUNOLOGY, 2016, 1 (01)
  • [7] Temsavir treatment of HIV-1-infected cells decreases envelope glycoproteins recognition by broadly-neutralizing antibodies
    Boutin, M.
    Vezina, D.
    Ding, S.
    Prevost, J.
    Laumaea, A.
    Marchitto, L.
    Anand, S. P.
    Medjahed, H.
    Gendron-Lepage, G.
    Bourassa, C.
    Goyette, G.
    Clark, A.
    Richard, J.
    Finzi, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 7 - 8
  • [8] BROADLY NEUTRALIZING ANTIBODIES TO HIV-1 IN INFECTED INDIVIDUALS
    REITZ, MS
    WATKINS, BA
    LOUIE, A
    GALLO, RC
    ROBERTGUROFF, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 301 - 301
  • [9] EPITOPES RECOGNIZED BY THE NEUTRALIZING ANTIBODIES OF AN HIV-1-INFECTED INDIVIDUAL
    PROFY, AT
    SALINAS, PA
    ECKLER, LI
    DUNLOP, NM
    NARA, PL
    PUTNEY, SD
    JOURNAL OF IMMUNOLOGY, 1990, 144 (12): : 4641 - 4647
  • [10] EARLY DEVELOPMENT OF BROADLY NEUTRALISING ANTIBODIES IN HIV-1-INFECTED INFANTS
    Mbugua, Njeri
    Bukusi, Elizabeth Ann
    Wagura, Asunta
    Ngugi, Elizabeth
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : A158 - A158